论文部分内容阅读
目的：对比观察低分子肝素与利伐沙班对老年股骨颈骨折行全髋关节置换术后隐性失血的影响。方法回顾分析我院骨科2010年1月~2014年6月所有行全髋关节置换的老年股骨颈骨折患者65例,按照术后应用的抗凝药物不同分为两组,其中低分子肝素31例,利伐沙班34例,观察两组术后总失血量、显性失血量并计算隐性失血量。结果低分子肝素组失血总量为(715.7±192.6)ml,其中显性失血量(251.5±84.3)ml、隐性失血量(464.2±134.5)ml；利伐沙班组失血总量为(600.4±203.8)ml,其中显性失血量(242.6±95.4)ml、隐性失血量(357.8±115.2)ml。两组比较,失血总量及隐性失血量差异有统计学意义(<0.05)。结论利伐沙班较低分子肝素可减少老年股骨颈骨折行全髋关节置换术患者术后隐性失血。“,”Objective To compare the ef ects of low molecular heparin and rivaroxaban in hidden blood loss after the operation of femoral neck fracture in the elderly. Methods We retrospectively studied 65 patients with femoral neck fracture in the elderly treated with total hip arthroplasty (THA) between January 2010 and June 2014, 34 were assigned into the observation group of rivaroxaban and 31 into the control group of low molecular heparin, calculated the hidden blood in both groups by observing the total blood loss and dominant blood loss after operation. Results The total blood loss was(715.7±192.6)ml, the dominant blood loss was(251.5±84.3)ml, the hidden blood was(464.2±134.5)ml in group of low molecular heparin, and there was (600.4±203.8)ml of total blood loss and (242.6±95.4)ml of dominant blood loss and (357.8±115.2)ml of hidden blood loss in group of rivaroxaban , the dif erence was significant ( <0.05). Conclusion The ef ect of rivaroxaban on hidden blood after THA treatment for femoral neck fractures in the elderly was lit le than low molecular heparin.